SYNTHON HISPANIA SL
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Medicinal Chemicals and Botanical Products), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about SYNTHON HISPANIA SL
Live alerts from global media, monitored by Business Radar
2025-01-16 (mena.nl)
League Tables 2024: The final score for -law firms is known -
View the League Tables advertisement in the FD here. With 36 completed transactions and a total deal value of almost seventeen billion euros in 2024, De Brauw Blackstone Westbroek has had an impressive year. Some of the most high-profile deals the firm has worked on include the FrieslandCampina merger (deal value: 1.3 billion euros), the […]
Read more
2025-01-08 (expresspharma.in)
Deal value declined by 86.4 per cent in Dec 2024, compared to Dec 2023 -
Three major deals contributed 70 per cent of the total deal value during December 2024
Read more
2024-12-17 (investorsinhealthcare.com)
Netherlands: BC Partners sells stake in Synthon to Goldman Sachs Alternatives for reported US$2bn valuation - Investors in Healthcare
BC Partners sells stake in Synthon to Goldman Sachs Alternatives
Read more
2024-12-16 (citeline.com)
Goldman Sachs Takes Control Of Synthon
Synthon’s current owners, BC Partners, are selling a controlling stake in the Dutch complex generics specialist to Goldman Sachs Asset Management.
Read more
2019-07-02 (businesswire.com)
BC Partners to Acquire Synthon International Holding B.V., a Global Market Leader in the Development of Complex Generics
Funds advised by BC Partners (“BC Partners”), a leading international private equity firm, have reached an agreement to acquire a majority stake in Sy
Read more
2016-07-22 (vastgoedberichten.nl)
Synthon buys business complex in Nijmegen
Synthon purchases the business complex located on a corner location at Lagelandseweg 51-53-55 and Microweg 2 in Nijmegen. The property consists of 3,102 m² of commercial and office space on a plot of 4,608 m². Synthon is the largest Dutch independent pharmaceutical company.
Read more
2010-03-09 (outsourcing-pharma.com)
synthon continues latin america expansion with nafar buy
Synthon has completed the acquisition of Mexico-based Nafar Laboratories, adding to its presence in Latin America which includes recent purchases in Chile and Argentina.
Read more
2008-09-08 (fiercebiotech.com)
Perrigo Company (PRGO) Acquires Exclusive Sales
Perrigo Company( PRGO) Acquires Exclusive Sales and Distribution Rights to Allergy Drug Levocetirizine from Synthon Pharmaceuticals ALLEGAN, Mich., Sept.8 /PRNewswire-FirstCall/ -- Perrigo Company| Perrigo Company( PRGO) Acquires Exclusive Sales and Distribution Rights to Allergy Drug Levocetirizine
Read more